EPHS Holdings Inc. (OTCQB:STNN) (“EPHS” or the “Company”), together with its joint venture partner, Merritt Valley Cannabis, is pleased to announce its Montreal cultivation plans have commenced, as per Health Canada sales licence regulations and inspections.

The EPHS state-of-the-art facility located in Montreal, Quebec is ready for immediate production and scale. EPHS is commencing with the Health Canada sales license process.


EPHS will continue to scale cannabis production at its Merritt site with the granting of additional Health Canada licenses. Ground breaking is scheduled for early 2019 for phase one of the 30,000 square foot state-of-the-art Cannabis Campus. The campus is expected to produce a supply of 5,500 plus kilograms of cannabis per year by early 2020.

EPHS CEO, Gianfranco Bentivoglio, stated “Our vision is to be unique, and the EPHS business model is built on simplicity and focus. It is our objective to build more efficiently and deliver cannabis to the under-supplied Canadian and global markets.”

Bentivoglio ended by stating “Canadian press ran many articles on supply shortages and long lines, and EPHS’ business and project plans have been developed to address these shortages and demands.”

Having Steve Perry, former Vice President of Energy and Major Projects for The Green Organic Dutchman Holdings Ltd. (US:TGODF) (TSX:TGOD), provides proven experience vital to scaling supply to serve the high demand market. EPHS and Merritt Valley Cannabis’ 1.2 million square foot Cannabis Campus located in Merritt BC will be capable of producing in excess of 100,000 kilograms of cannabis product over the next five years to serve global market demands.

About EPHS Holdings Inc.

EPHS Holdings Inc., together with its joint venture partner, Merritt Valley Cannabis, is a licensed commercial cannabis cultivator engaging in the cultivation, possession, research, processing, sales and distribution of medicinal and recreational cannabis under the laws of the Health Canada ACMPR license.

Forward-Looking Statements

Certain statements contained in this news release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” are based on expectations, estimates and projections at the time the statements are made, and involve risks and uncertainties, which could cause actual results or events to differ materially from those currently anticipated, including, but not limited to delays, difficulties, changed strategies, or unanticipated factors or circumstances affecting EPHS Holdings, Inc. and its business. Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, the Company does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it is not possible for the Company to predict all such factors. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements found in the Company’s filings with the SEC, including, but not limited to, its Annual Report on Form 10-K, its subsequent Quarterly Reports on Form 10-Q, and its Current Reports on Form 8-K. The risk factors and other factors noted in the Company’s SEC filings could cause actual results to differ materially from those contained in any forward-looking statement.

About Emerald Plants Health Source

www.ephsholdings.com

Contacts

EPHS Holdings Inc.
John Bentivoglio, 1-516-754-7604
info@ephsholdings.com

Source: www.businesswire.com

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce its upcoming investor awareness initiatives. MustGrow continues to actively engage its key stakeholders – potential industry partners, shareholders and prospective investors – by increasing awareness of its remarkable natural mustard-derived crop protection products.

TODAY: The Future of Food Investment Conference – SnowCap Ventures
Tuesday, Nov. 24th at 1:50 pm ET
Investors Register Here

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) is pleased to announce the launch of a customer rewards program called “Insider Rewards” for its Urban Juve skin care line.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/68816_d5e319fef42e2b1a_001.jpg

Keep reading... Show less

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Trading resumes in:

Company: 4Front Ventures Corp.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /

  4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) is pleased to announce that it has completed its previously announced bought deal prospectus offering (the ” Offering “) of units of the Company (” Units “), for aggregate gross proceeds of C$17,251,150 including full exercise of the over-allotment option granted to the underwriters in connection therewith.

Keep reading... Show less